201 related articles for article (PubMed ID: 15362874)
21. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.
Sinha D; Seaman FS; Walsh PN
Biochemistry; 1987 Jun; 26(13):3768-75. PubMed ID: 3498513
[TBL] [Abstract][Full Text] [Related]
22. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX.
Persson KE; Knobe KE; Stenflo J
Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405
[TBL] [Abstract][Full Text] [Related]
23. Factor XIa dimer in the activation of factor IX.
Sinha D; Marcinkiewicz M; Lear JD; Walsh PN
Biochemistry; 2005 Aug; 44(30):10416-22. PubMed ID: 16042419
[TBL] [Abstract][Full Text] [Related]
24. Protease nexin II interactions with coagulation factor XIa are contained within the Kunitz protease inhibitor domain of protease nexin II and the factor XIa catalytic domain.
Badellino KO; Walsh PN
Biochemistry; 2000 Apr; 39(16):4769-77. PubMed ID: 10769134
[TBL] [Abstract][Full Text] [Related]
25. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
Schapira M; Scott CF; Colman RW
Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
[No Abstract] [Full Text] [Related]
26. Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
Walsh PN; Sinha D; Kueppers F; Seaman FS; Blankstein KB
J Clin Invest; 1987 Dec; 80(6):1578-86. PubMed ID: 3500185
[TBL] [Abstract][Full Text] [Related]
27. The mechanism underlying activation of factor IX by factor XIa.
Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
[TBL] [Abstract][Full Text] [Related]
28. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
[TBL] [Abstract][Full Text] [Related]
29. Factor XIa induced activation of the intrinsic cascade in vivo.
ten Cate H; Biemond BJ; Levi M; Wuillemin WA; Bauer KA; Barzegar S; Buller HR; Hack CE; ten Cate JW; Rosenberg RD
Thromb Haemost; 1996 Mar; 75(3):445-9. PubMed ID: 8701405
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
Sinha D; Koshy A; Seaman FS; Walsh PN
J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
[TBL] [Abstract][Full Text] [Related]
31. A sequential mechanism for exosite-mediated factor IX activation by factor XIa.
Geng Y; Verhamme IM; Messer A; Sun MF; Smith SB; Bajaj SP; Gailani D
J Biol Chem; 2012 Nov; 287(45):38200-9. PubMed ID: 22961984
[TBL] [Abstract][Full Text] [Related]
32. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
Baglia FA; Sinha D; Walsh PN
Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
[TBL] [Abstract][Full Text] [Related]
33. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
[TBL] [Abstract][Full Text] [Related]
34. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.
van der Graaf F; Greengard JS; Bouma BN; Kerbiriou DM; Griffin JH
J Biol Chem; 1983 Aug; 258(16):9669-75. PubMed ID: 6604052
[TBL] [Abstract][Full Text] [Related]
35. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
36. Update on the physiology and pathology of factor IX activation by factor XIa.
Smith SB; Gailani D
Expert Rev Hematol; 2008 Oct; 1(1):87-98. PubMed ID: 19714257
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
39. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
Neuenschwander PF
Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
[TBL] [Abstract][Full Text] [Related]
40. Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation.
Maekawa H; Sugo T; Yamashita N; Kamiya K; Umeyama H; Miura N; Naka H; Nishimura T; Yoshioka A; Matsuda M
Biochemistry; 1993 Jun; 32(24):6146-51. PubMed ID: 8512923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
